HUMA

Humacyte Inc

• NASDAQ·12h ago

  Wall Street Bulls Look Optimistic About Humacyte, Inc. (HUMA): Should You Buy?

• TipRanks·3d ago

  Analysts Offer Insights on Healthcare Companies: Climb Bio (CLYM), Humacyte (HUMA) and Phathom Pharmaceuticals (PHAT)

• Dow Jones·3d ago

  Humacyte Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

• Benzinga·3d ago

  HC Wainwright & Co. Reiterates Buy on Humacyte, Maintains $3 Price Target

• TipRanks·3d ago

  Humacyte announces presentation at VASA meeting on self-repair ATEV

• PUBT·3d ago

  Humacyte says interim Phase 3 dialysis access study results due June 11

• TipRanks·05/21 12:45

  Largest borrow rate increases among liquid names

• TipRanks·05/21 02:11

  High-Profile Director Makes Bold Move Into Humacyte Shares

• PUBT·05/20 20:33

  Humacyte director Kathleen Sebelius acquires 56,818 shares for $49,999.84

• PUBT·05/20 20:32

  Humacyte director Michael T. Constantino acquires common shares worth $9,840

• TipRanks·05/20 12:14

  Humacyte reports Symvess under contract with Strategic Acquisition Center of VA

• PUBT·05/20 12:03

  Humacyte Symvess wins U.S. Veterans Affairs Strategic Acquisition Center contract

• Benzinga·05/20 12:02

  Humacyte Says Symvess Is Now Under Contract With Strategic Acquisition Center Of US Department Of Veterans Affairs

• Reuters·05/20 12:00

  HUMACYTE ANNOUNCES SYMVESS® IS NOW UNDER CONTRACT WITH THE STRATEGIC ACQUISITION CENTER (SAC) OF THE U.S. DEPARTMENT OF VETERANS AFFAIRS

• Dow Jones·05/20 12:00

  Press Release: Humacyte Announces Symvess(R) is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs